Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

Beer Hops May Influence Next Generation of Medicine

By Drug Discovery Trends Editor | March 17, 2016

As you raise your pint glass on St. Patrick’s Day, know that the hops in that beer you’re drinking have medicinal potential. But the amber liquid you’re guzzling probably isn’t the best delivery mechanism.

“Even if you’re getting a medicinal amount, you’re not getting it in probably the best way,” said Univ. of Idaho’s Kristopher Waynant. “We all now there’s positive effects from drinking beer, but I don’t think those positive effects are medicinal.”

Waynant briefed the press on his team’s research regarding the medicinal power of beer hops at the 251st National Meeting & Exposition of the American Chemical Society, which was held in San Diego.

Beer hops contain compounds known as humulones and lupulones, the former are alpha acids and the latter are beta acids. These compounds are found in the resin material of hop cones, and are responsible for endowing beer with its bitter taste. According to Waynant, alpha acids possess antibacterial properties and are integral to preventing beer spoilage. Further, a myriad of studies have shown they possess anti-inflammatory and anticancer properties.

“But just because a natural compound is biologically active doesn’t mean that it should be a medicine,” Waynant said. “Or that doesn’t mean it’s going to be a great medicine.”

“We are working on synthesizing humulone and lupulone derivatives,” said Waynant, noting that his team of synthetic chemists are trying to create compounds with higher degrees of bioactivity than their natural counterparts.

Waynant said the team is creating a library of compounds, with hopes of producing between 10 and 20 that will go on for screening. He mentioned the team is working with a pharmaceutical company on the project. They’re searching for synthesizing methods that can enhance the compounds, thereby making them better medicinal agents.   

The process isn’t without its difficulties. “The researchers start with phloroglucinol—a commercially available compound that is derived from plants,” according to the American Chemical Society. “So far, they have been developing multi-step processes to synthesize three types of humulones…The team is still working on tweaking the final step of converting the intermediate products in the desired humulones efficiently.”

Waynant’s team hopes their work will help create the next generation of medicines.  

R&D 100 AWARD ENTRIES NOW OPEN:

Establish your company as a technology leader! For more than 50 years, the R&D 100 Awards have showcased new products of technological significance. You can join this exclusive community! Learn more.


Filed Under: Drug Discovery

 

Related Articles Read More >

4D Path/PathPresenter
How 4D Path and PathPresenter aim to further AI-enabled digital pathology for breast tumor profiling
Moderna
Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
Lab facility
Massachusetts is competing for ARPA-H biomedical research center
Blockchain
Startup vies to get blockchain adoption in pharma off the ground

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50